Cetero inks deal as interest in Phase I partnerships grows
Cetero has inked an early stage preferred provider agreement and is eyeing other deals as sponsors look to extend the partnership model into Phase I.
Cetero has inked an early stage preferred provider agreement and is eyeing other deals as sponsors look to extend the partnership model into Phase I.
SGS plans to set up its second life sciences services centre in India later this year.
Indian drugmakers Serum Institute and Panacea Biotech have reduced what they charge the GAVI for vaccines, prompting similar commitments from several Big Pharma firm.
US generics maker Impax Laboratories says it has started addressing cGMP deviations observed by regulators at California manufacturing plant.